THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

REGISTER NOW!
Already Registered?
SIGN IN

WEBCAST DATE

MONDAY, NOVEMBER 6, 2017

6:00 PM Eastern    5:00 PM Central    4:00 PM Mountain    3:00 PM Pacific

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

Faculty

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

AGENDA

I. Overview of headache disorders

II. Migraine Epidemiology and burden

III. Pathophysiology of migraine (3D video)

IV. Challenges in the diagnosis of primary headache disorders
  ○ Headache diversity
  ○ Differential diagnosis

V. Management of migraine
  ○ Pharmacologic regimens
    ▪ Triptans and ergot derivatives
    ▪ Non-triptan serotonin receptor agonist therapy
  ○ Preventive regimens
  ○ Non-pharmacologic Interventions
  ○ New and emerging agents/devices for the management of primary headache disorders
    ▪ Anti CGRP mAbs (3D video)
    ▪ Neuromodulation devices

VI. Interactive Case Studies

VII. Conclusions

VIII. Questions and Answers

IX. Summary and adjournment

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose:

This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

2.00 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT REQUEST

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017, has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.